Lycia Therapeutics (LYCA)
NASDAQ · Health Care · Biological Products, (No Diagnostic Substances)
Biological Products, (No Diagnostic Substances) company based in South San Francisco, CA. Listed, but no annual report (10-K) filed yet under this SEC registration.
As of Oct 28, 2026, OQRO holds for Lycia Therapeutics (LYCA) over the last 12 months: 20 insider filings, 0 Congress trades, 0 fund positions and 0 federal contract awards. Most recent on file: 10% owner purchased ~$631K of LYCA shares in the open market, traded Oct 23, 2026, filed Oct 27, 2026.
Last 30 days
Written by software from the filings listed below · Oct 28, 2026
- Insiders Lycia Therapeutics on OQRO: In the 30 days to Oct 28, 2026, insiders filed 6 open-market purchases (about $37.7M, in 1 filing, by 1 person) and 0 open-market sales. The largest purchase was by Venrock Healthcare Capital Partners III, L.P., a 10% owner, about $35M, filed Oct 27, 2026.
2 more points, with the facts they come from, are in OQRO Pro.
Start free trialExample public filing
10% owner bought ~$631K
Venrock Healthcare Capital Partners III, 10% owner at Lycia Therapeutics, bought ~$631K of Lycia Therapeutics shares.
- ~$631K
- Approx. value · 25K sh @ $25.68
- 25K
- Holds after · shares reported
- Traded
- Oct 23, 2026
- Filed
- Oct 27, 2026
Data as of Oct 28, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.
On file for LYCA, last 12 months
- 20
- Insider filings
- 0
- Congress trades
- 0
- Fund positions
- 0
- Federal contracts
Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.
Insider buying and selling since 2026
Insiders of Lycia Therapeutics reported 6 open-market purchases and 0 sales since 2026; purchases in 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 6×6 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
See the full picture with OQRO Pro.
20 records for Lycia Therapeutics in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.
Latest disclosures
3 days free for first-time subscribers, then $9.99 a month. Nothing is charged today: your card is charged when the trial ends unless you cancel before, from your account. Secure payment by Stripe.
Public previews are free. Full research is OQRO Pro, with a 3-day free trial to start: your card is charged only when the trial ends.
Free account: get the written context of this page, built from its filings.
What this page holds
- Insider trades and planned sales
- Politician trades (House and Senate)
- Fund holdings from 13F filings
- Federal contracts, lobbying and short selling
- Full history and context, with a link to every filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Lycia Therapeutics insider trading
Have Lycia Therapeutics insiders bought shares recently?
Yes. Insiders of Lycia Therapeutics (LYCA) filed 6 open-market purchases in the last 90 days; the latest was filed on Oct 27, 2026.
How often do Lycia Therapeutics insiders buy and sell shares?
Since 2026, Lycia Therapeutics insiders reported 6 open-market purchases and 0 sales on Forms 4 and 5, with purchases in 1 different year, most recently 2026.
Do members of Congress trade LYCA?
No trade in Lycia Therapeutics (LYCA) was disclosed by a member of Congress in the last 12 months.
Where does this data come from?
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.